As of 2024-12-14, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (35.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.43 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -1571.7%.
The range of the Relative Valuation is (32.77) - (36.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 33.2x | 30.7x |
| Forward P/E multiples | 28.0x - 31.6x | 30.4x |
| Fair Price | (32.77) - (36.96) | (35.76) |
| Upside | -1448.7% - -1621.0% | -1571.7% |
| Date | P/E |
| 2024-12-05 | -1.77 |
| 2024-12-04 | -1.87 |
| 2024-12-03 | -1.87 |
| 2024-12-02 | -1.87 |
| 2024-11-29 | -1.88 |
| 2024-11-27 | -1.83 |
| 2024-11-26 | -1.88 |
| 2024-11-25 | -1.81 |
| 2024-11-22 | -1.80 |
| 2024-11-21 | -1.81 |
| 2024-11-20 | -1.85 |
| 2024-11-19 | -1.85 |
| 2024-11-18 | -1.79 |
| 2024-11-15 | -2.06 |
| 2024-11-14 | -2.68 |
| 2024-11-13 | -2.74 |
| 2024-11-12 | -2.73 |
| 2024-11-11 | -2.75 |
| 2024-11-08 | -2.71 |
| 2024-11-07 | -2.75 |
| 2024-11-06 | -2.77 |
| 2024-11-05 | -2.64 |
| 2024-11-04 | -2.24 |
| 2024-11-01 | -2.33 |
| 2024-10-31 | -2.41 |
| 2024-10-30 | -2.50 |
| 2024-10-29 | -2.44 |
| 2024-10-28 | -2.48 |
| 2024-10-25 | -2.39 |
| 2024-10-24 | -2.45 |
| 2024-10-23 | -2.39 |
| 2024-10-22 | -2.45 |
| 2024-10-21 | -2.57 |
| 2024-10-18 | -2.68 |
| 2024-10-17 | -2.62 |
| 2024-10-16 | -2.74 |
| 2024-10-15 | -2.68 |
| 2024-10-14 | -2.74 |
| 2024-10-11 | -2.56 |
| 2024-10-10 | -2.47 |
| 2024-10-09 | -2.59 |
| 2024-10-08 | -2.65 |
| 2024-10-07 | -2.74 |
| 2024-10-04 | -2.38 |
| 2024-10-03 | -2.18 |
| 2024-10-02 | -2.29 |
| 2024-10-01 | -2.41 |
| 2024-09-30 | -2.33 |
| 2024-09-27 | -2.45 |
| 2024-09-26 | -2.32 |